•
ZU
ZURA
Zura Bio Limited Class A Ordinary Shares
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
410.95M
Volume
550.85K
52W High
$6.63
52W Low
$0.97
Open
$6.31
Prev Close
$6.32
Day Range
6.12 - 6.63
About Zura Bio Limited Class A Ordinary Shares
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Latest News
Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight
GlobeNewswire Inc.•Oct 23
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga•Sep 29
Wall Street Analysts Predict a 235.2% Upside in Zura Bio Limited (ZURA): Here's What You Should Know
Zacks Investment Research•May 31
How Much Upside is Left in Zura Bio Limited (ZURA)? Wall Street Analysts Think 248.84%
Zacks Investment Research•May 15
Zura Bio Limited (ZURA) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research•May 14
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Benzinga•Oct 10
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
Benzinga•Aug 25
Where Zura Bio Stands With Analysts
Benzinga•Aug 15